BE858709A - Procede de preparation de steroides halogenes en positions 9,11, et les composes obtenus par le procede - Google Patents
Procede de preparation de steroides halogenes en positions 9,11, et les composes obtenus par le procedeInfo
- Publication number
- BE858709A BE858709A BE180914A BE180914A BE858709A BE 858709 A BE858709 A BE 858709A BE 180914 A BE180914 A BE 180914A BE 180914 A BE180914 A BE 180914A BE 858709 A BE858709 A BE 858709A
- Authority
- BE
- Belgium
- Prior art keywords
- positions
- compounds obtained
- preparing halogen
- halogen steroids
- steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU75809A LU75809A1 (de) | 1976-09-16 | 1976-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE858709A true BE858709A (fr) | 1978-03-15 |
Family
ID=19728351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE180914A BE858709A (fr) | 1976-09-16 | 1977-09-15 | Procede de preparation de steroides halogenes en positions 9,11, et les composes obtenus par le procede |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5337652A (de) |
| AT (1) | AT356303B (de) |
| AU (1) | AU514425B2 (de) |
| BE (1) | BE858709A (de) |
| CA (1) | CA1105003A (de) |
| DE (1) | DE2741067A1 (de) |
| DK (1) | DK410077A (de) |
| FR (1) | FR2364928A1 (de) |
| GB (1) | GB1584826A (de) |
| LU (1) | LU75809A1 (de) |
| NL (1) | NL7710086A (de) |
| SE (1) | SE7710337L (de) |
| ZA (1) | ZA775537B (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4358445A (en) | 1979-11-16 | 1982-11-09 | Macdonald Peter | 6α-Fluoro-prednisdone 17,21 diesters |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209140B (it) * | 1979-11-16 | 1989-07-10 | Prochem Ets | 6 alfa-fluoro-prednisolone 17,21-diesteri. |
-
1976
- 1976-09-16 LU LU75809A patent/LU75809A1/xx unknown
-
1977
- 1977-09-13 DE DE19772741067 patent/DE2741067A1/de not_active Withdrawn
- 1977-09-14 CA CA286,727A patent/CA1105003A/en not_active Expired
- 1977-09-14 FR FR7727739A patent/FR2364928A1/fr active Granted
- 1977-09-14 GB GB38343/77A patent/GB1584826A/en not_active Expired
- 1977-09-14 NL NL7710086A patent/NL7710086A/xx not_active Application Discontinuation
- 1977-09-15 SE SE7710337A patent/SE7710337L/ not_active Application Discontinuation
- 1977-09-15 DK DK410077A patent/DK410077A/da unknown
- 1977-09-15 ZA ZA00775537A patent/ZA775537B/xx unknown
- 1977-09-15 AT AT663077A patent/AT356303B/de not_active IP Right Cessation
- 1977-09-15 BE BE180914A patent/BE858709A/xx unknown
- 1977-09-15 AU AU28848/77A patent/AU514425B2/en not_active Expired
- 1977-09-16 JP JP11060977A patent/JPS5337652A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4358445A (en) | 1979-11-16 | 1982-11-09 | Macdonald Peter | 6α-Fluoro-prednisdone 17,21 diesters |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1105003A (en) | 1981-07-14 |
| ATA663077A (de) | 1979-09-15 |
| FR2364928A1 (fr) | 1978-04-14 |
| DK410077A (da) | 1978-03-17 |
| NL7710086A (nl) | 1978-03-20 |
| AU514425B2 (en) | 1981-02-12 |
| AT356303B (de) | 1980-04-25 |
| GB1584826A (en) | 1981-02-18 |
| AU2884877A (en) | 1979-03-22 |
| SE7710337L (sv) | 1978-03-17 |
| ZA775537B (en) | 1978-07-26 |
| LU75809A1 (de) | 1978-05-12 |
| JPS5337652A (en) | 1978-04-06 |
| DE2741067A1 (de) | 1978-03-23 |
| FR2364928B1 (de) | 1981-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2314197A1 (fr) | Procede de preparation d'oxo-20 steroides insatures en 9,11 | |
| FR2301505A1 (fr) | Procede de preparation de 2,2-dimethylolalcanals | |
| FR2313357A1 (fr) | Procede de preparation du 1,4-diaminoanthraquinone-2,3-dinitrile | |
| BE841285A (fr) | Procede de preparation d'acetoacetyl-arylamides | |
| FR2347345A1 (fr) | Procede de preparation d'alkylthiomethylphenols | |
| FR2345434A1 (fr) | Procede de preparation de la 5-acetoacetylamino-benzimidazolone | |
| FR2312480A1 (fr) | Procede de preparation du 2,5-dichlorotoluene | |
| FR2341529A1 (fr) | Procede de preparation de b''-a12o3 | |
| BE865728A (fr) | Procede de preparation du 2,3-dimethylpentanal | |
| BE861064A (fr) | Procede de preparation de siph2nylamine styrenee | |
| BE855371A (fr) | Procede de preparation de 1,1-difluorethylene | |
| FR2315273A1 (fr) | Procede de preparation d'indoloquinolizines | |
| BE858709A (fr) | Procede de preparation de steroides halogenes en positions 9,11, et les composes obtenus par le procede | |
| FR2333805A1 (fr) | Procede de preparation de n,n'-bis-trimethylsilyluree | |
| FR2299329A1 (fr) | Procede de preparation de 1,2-benzisothiazoles | |
| BE844433A (fr) | Procede de preparation de chloro-2 butadiene-1,3 | |
| BE841761A (fr) | Procede de preparation de la 2, 5-dimethoxy-4-chloraniline | |
| FR2344564A2 (fr) | Procede de preparation de 2,5-dioxo-1,2-oxa-phospholannes | |
| FR2307781A1 (fr) | Procede de preparation d'acenaphtenes | |
| BE843910A (fr) | Procede de preparation de 2,5-dioxo-1-oxa-2-phospholanes | |
| BE861501A (fr) | Procede de preparation de la 17alpha-hydroxy-21-acetoxy-progesterone | |
| BE843500A (fr) | Procede de preparation d'oxaphospholannes-1,2, | |
| FR2305432A1 (fr) | Procede de preparation de 3,5-dialcoyl-4-mercapto-phenol | |
| BE840837A (fr) | Procede de preparation de la 1,8-dinitro-anthraquinone pure | |
| BE859998A (fr) | Procede de preparation de dihalogenures dioganostanniques |